Ellis Andrea (CIK 1877680) reported 10 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-06-24). Recent activity: Buy BBIO (3,990 shares), Buy BBIO (64,921 shares), Sell BBIO (64,921 shares), Buy BBIO (17,167 shares), Sell BBIO (17,167 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-24 | BridgeBio Pharma, Inc. (BBIO) | Director | Buy | 3,990 | $0 |
| 2026-03-06 | BridgeBio Pharma, Inc. (BBIO) | Director | Buy | 64,921 | $548,582 |
| 2026-03-06 | BridgeBio Pharma, Inc. (BBIO) | Director | Sell | 64,921 | $4.2M |
| 2025-08-07 | BridgeBio Pharma, Inc. (BBIO) | Director | Buy | 17,167 | $287,547 |
| 2025-08-07 | BridgeBio Pharma, Inc. (BBIO) | Director | Sell | 17,167 | $841,183 |
| 2025-06-24 | BridgeBio Pharma, Inc. (BBIO) | Director | Buy | 6,589 | $0 |
| 2025-04-16 | BridgeBio Pharma, Inc. (BBIO) | Director | Buy | 10,000 | $84,500 |
| 2025-04-16 | BridgeBio Pharma, Inc. (BBIO) | Director | Sell | 10,000 | $350,000 |
| 2025-04-03 | BridgeBio Pharma, Inc. (BBIO) | Director | Buy | 30,000 | $253,500 |
| 2025-04-03 | BridgeBio Pharma, Inc. (BBIO) | Director | Sell | 30,000 | $1.0M |
Source: SEC Form 4 filings · as of 2026-06-24